Mawer Investment Management Ltd. Has $60.06 Million Position in CVS Health Co. (NYSE:CVS)

Mawer Investment Management Ltd. reduced its holdings in CVS Health Co. (NYSE:CVS) by 1.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,016,870 shares of the pharmacy operator’s stock after selling 12,033 shares during the quarter. Mawer Investment Management Ltd. owned about 0.08% of CVS Health worth $60,056,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in CVS. Wedmont Private Capital lifted its stake in shares of CVS Health by 0.8% in the first quarter. Wedmont Private Capital now owns 19,225 shares of the pharmacy operator’s stock valued at $1,410,000 after buying an additional 146 shares during the period. Moody National Bank Trust Division lifted its stake in shares of CVS Health by 0.7% in the first quarter. Moody National Bank Trust Division now owns 22,268 shares of the pharmacy operator’s stock valued at $1,776,000 after buying an additional 150 shares during the period. Landmark Financial Advisors LLC lifted its stake in shares of CVS Health by 3.8% in the fourth quarter. Landmark Financial Advisors LLC now owns 4,166 shares of the pharmacy operator’s stock valued at $329,000 after buying an additional 153 shares during the period. Garland Capital Management Inc. lifted its stake in shares of CVS Health by 0.3% in the second quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock valued at $3,591,000 after buying an additional 160 shares during the period. Finally, Sepio Capital LP lifted its stake in shares of CVS Health by 1.7% in the fourth quarter. Sepio Capital LP now owns 9,907 shares of the pharmacy operator’s stock valued at $782,000 after buying an additional 163 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Performance

Shares of CVS Health stock opened at $56.47 on Tuesday. The firm has a 50 day simple moving average of $58.26 and a 200 day simple moving average of $63.54. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The firm has a market cap of $71.04 billion, a P/E ratio of 9.92, a P/E/G ratio of 0.81 and a beta of 0.54.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm had revenue of $91.23 billion during the quarter, compared to analyst estimates of $91.41 billion. During the same quarter in the previous year, the business earned $2.21 EPS. The business’s quarterly revenue was up 2.6% compared to the same quarter last year. Sell-side analysts predict that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.71%. The ex-dividend date of this dividend was Monday, July 22nd. CVS Health’s dividend payout ratio is presently 46.75%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CVS. Royal Bank of Canada restated an “outperform” rating and set a $68.00 price target on shares of CVS Health in a research note on Wednesday, September 4th. Robert W. Baird began coverage on shares of CVS Health in a research note on Thursday, May 30th. They set a “neutral” rating and a $61.00 price target for the company. Deutsche Bank Aktiengesellschaft cut their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Evercore ISI cut their price target on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Finally, Barclays cut their target price on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating for the company in a research note on Thursday, August 8th. Eleven analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $72.48.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.